2021
DOI: 10.1016/j.celrep.2021.108751
|View full text |Cite
|
Sign up to set email alerts
|

Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy

Abstract: SUMMARY The myeloid tumor suppressor KMT2C is recurrently deleted in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), particularly therapy-related MDS/AML (t-MDS/t-AML), as part of larger chromosome 7 deletions. Here, we show that KMT2C deletions convey a selective advantage to hematopoietic stem cells (HSCs) after chemotherapy treatment that may precipitate t-MDS/t-AML. Kmt2c deletions markedly enhance murine HSC s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 67 publications
(97 reference statements)
1
14
1
Order By: Relevance
“…The second highly expressed transcript is Kmt2c (lysine methyltransferase 2C), which is a tumour suppressor mutated or deleted in the peripheral T-cell lymphoma ( Watatani et al., 2019 ) and myelodysplastic syndrome (MDS) ( Chen et al., 2021 ). KMT2C upregulation modifies histones during NK-cell activation in humans, helping the rapid shift in the expression of particular genes above the baseline during the target recognition process ( Li et al., 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…The second highly expressed transcript is Kmt2c (lysine methyltransferase 2C), which is a tumour suppressor mutated or deleted in the peripheral T-cell lymphoma ( Watatani et al., 2019 ) and myelodysplastic syndrome (MDS) ( Chen et al., 2021 ). KMT2C upregulation modifies histones during NK-cell activation in humans, helping the rapid shift in the expression of particular genes above the baseline during the target recognition process ( Li et al., 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Cells were isolated, stained, analyzed and transplanted as previously described. 14, 20, 21 Flow cytometry antibodies and surface marker phenotypes are defined in Table S1, and representative gating strategies are shown in Figures S2, S4 and S5. Flow cytometry was performed on a BD FACSAria Fusion flow cytometer (BD Biosciences).…”
Section: Methodsmentioning
confidence: 99%
“…Cells were isolated, stained, analyzed and transplanted as previously described. 14,20,21 Flow cytometry antibodies and surface marker phenotypes are defined in Table S1…”
Section: Flow Cytometrymentioning
confidence: 99%
“…The transformation to leukemia requires additional mutations that activate oncogenes (like FLT3 or RAS ) or inactivate tumor suppressors (like TP53 or CEBPA ) [ 175 ]. Interestingly, specifically KMT2C inactivating mutations have been shown to enhance the self-renewal capacity of hematopoietic stem cells [ 176 ].…”
Section: Consequences Of Chromatin Regulator Alterations In Urothelial Carcinomamentioning
confidence: 99%